XCRT: Dedicated to “Xcelerating the growth, success and full potential of MedTech Development & Healthcare Delivery with End to End Control.”

Business Description:  Xcelerate has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care.

The Company acquires innovation at the engineering / patent level, marries it with appropriate early-stage operational med tech companies and applies it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella.

Key Metrics @ 04/24/2024

Closing Price	$0.0354
52 Week Range	$0.0277 to $0.1356
Shares Outstanding: 04/19/2024	434,446,072
Shares in the Float: 12/31/2023	113,254,437
Held @ DTC: 04/19/2024	123,962,566
Shares Authorized	1.00B
Average Volume (30 day)	116,947
Market Cap	$15,379,301
Reporting Status	SEC Reporting – Reg A
Financials	Audited
Most Recent: Quarterly Report 03/31/2022	Filed:  05/23/2022
Fiscal Year-end	12/31

(Source: Yahoo Finance, OTC Markets, SEC filings)

Go to Market Strategy:

In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry.

This includes (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology.

In 2022, the Company expanded this business plan to include the marketing and sale of over-the-counter healthcare products.

For more information visit the Company’s website at www.xcelerate.global  

Bottom Line Observation… Don’t Miss This One…!

XCRT is trading in a very attractive range and offers early movers the potential of significant upside gains… put this stock on your radar immediately or in your healthcare portfolio.

Research and Editorial Staff

MicroCap MarketPlace

_________________________________________________________________________

Disclaimer and Disclosures: MicroCap MarketPlace (MCMP) is a financial publisher and not a FINRA broker/dealer or investment adviser. MCMP is not registered with the SEC / U.S. Securities and Exchange Commission or any state securities regulatory agency. Readers, subscribers, and web site visitors are responsible for individual investment decisions. All information contained in our newsletters or on our web site and in our blogs should be independently verified with the featured companies and readers should always conduct their own research and due diligence and engage professional investment advisers as they deem appropriate before making investment decisions. Please review the Terms and Conditions of Use, including without limitation all disclaimers of warranties and limitations on liability contained therein. Your use of any information on our websites, contained herein or in our newsletters and blogs constitutes your agreement of same. Officers, employees, and affiliates may hold positions in the featured securities discussed in our newsletters or on our web site and blogs and may buy or sell said securities at any time without further notice. MCMP and/or affiliates may from time to time receive cash and/or equity compensation to provide corporate marketing and communications services for featured companies. In the interest of full disclosure, Mike Casson, MCMP’s Founder/Executive Editor is also president of Casson Communications, LLC (CCLLC) an affiliated company. CCLLC has been engaged by the featured company for a three-month investor relations and market awareness program. To date, CCLLC has received ten thousand dollars in cash compensation for these services. Therefore, you should be aware of potential conflicts of interest. We believe the information contained herein, and in our publications, to be reliable but cannot guarantee its accuracy; therefore, all information is provided as is without warranty of any kind. Past results are not necessarily indicative of future performance.

© 2024 MicroCap MarketPlace, All Rights Reserved